4-5689175-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147127.5(EVC2):​c.688A>G​(p.Ser230Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.225 in 1,613,956 control chromosomes in the GnomAD database, including 41,951 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3753 hom., cov: 33)
Exomes 𝑓: 0.23 ( 38198 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.22
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004810661).
BP6
Variant 4-5689175-T-C is Benign according to our data. Variant chr4-5689175-T-C is described in ClinVar as [Benign]. Clinvar id is 262620.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-5689175-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.371 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVC2NM_147127.5 linkc.688A>G p.Ser230Gly missense_variant Exon 5 of 22 ENST00000344408.10 NP_667338.3 Q86UK5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVC2ENST00000344408.10 linkc.688A>G p.Ser230Gly missense_variant Exon 5 of 22 1 NM_147127.5 ENSP00000342144.5 Q86UK5-1
EVC2ENST00000310917.6 linkc.448A>G p.Ser150Gly missense_variant Exon 5 of 22 1 ENSP00000311683.2 Q86UK5-2
EVC2ENST00000475313.5 linkn.448A>G non_coding_transcript_exon_variant Exon 5 of 23 1 ENSP00000431981.1 A0A0C4DGE7
EVC2ENST00000509670.1 linkn.448A>G non_coding_transcript_exon_variant Exon 6 of 23 1 ENSP00000423876.1 E9PFT2

Frequencies

GnomAD3 genomes
AF:
0.221
AC:
33675
AN:
152042
Hom.:
3746
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.196
Gnomad AMI
AF:
0.139
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.231
Gnomad EAS
AF:
0.385
Gnomad SAS
AF:
0.274
Gnomad FIN
AF:
0.229
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.236
GnomAD3 exomes
AF:
0.239
AC:
60173
AN:
251426
Hom.:
7513
AF XY:
0.241
AC XY:
32755
AN XY:
135876
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.252
Gnomad ASJ exome
AF:
0.220
Gnomad EAS exome
AF:
0.398
Gnomad SAS exome
AF:
0.260
Gnomad FIN exome
AF:
0.231
Gnomad NFE exome
AF:
0.214
Gnomad OTH exome
AF:
0.234
GnomAD4 exome
AF:
0.226
AC:
330040
AN:
1461796
Hom.:
38198
Cov.:
33
AF XY:
0.227
AC XY:
164757
AN XY:
727188
show subpopulations
Gnomad4 AFR exome
AF:
0.188
Gnomad4 AMR exome
AF:
0.250
Gnomad4 ASJ exome
AF:
0.224
Gnomad4 EAS exome
AF:
0.347
Gnomad4 SAS exome
AF:
0.258
Gnomad4 FIN exome
AF:
0.227
Gnomad4 NFE exome
AF:
0.219
Gnomad4 OTH exome
AF:
0.229
GnomAD4 genome
AF:
0.221
AC:
33693
AN:
152160
Hom.:
3753
Cov.:
33
AF XY:
0.225
AC XY:
16703
AN XY:
74390
show subpopulations
Gnomad4 AFR
AF:
0.196
Gnomad4 AMR
AF:
0.238
Gnomad4 ASJ
AF:
0.231
Gnomad4 EAS
AF:
0.386
Gnomad4 SAS
AF:
0.273
Gnomad4 FIN
AF:
0.229
Gnomad4 NFE
AF:
0.217
Gnomad4 OTH
AF:
0.232
Alfa
AF:
0.222
Hom.:
9748
Bravo
AF:
0.222
TwinsUK
AF:
0.224
AC:
831
ALSPAC
AF:
0.226
AC:
871
ESP6500AA
AF:
0.201
AC:
887
ESP6500EA
AF:
0.216
AC:
1856
ExAC
AF:
0.236
AC:
28714
Asia WGS
AF:
0.302
AC:
1047
AN:
3478
EpiCase
AF:
0.221
EpiControl
AF:
0.222

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 03, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Ellis-van Creveld syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Curry-Hall syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
15
DANN
Benign
0.80
DEOGEN2
Benign
0.051
T;.
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.61
T;T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.94
N;N
REVEL
Benign
0.099
Sift
Benign
0.13
T;T
Sift4G
Uncertain
0.025
D;D
Polyphen
0.081
B;.
Vest4
0.042
MPC
0.020
ClinPred
0.0024
T
GERP RS
1.9
Varity_R
0.067
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4689278; hg19: chr4-5690902; COSMIC: COSV60389850; API